mozavaptan has been researched along with Cardiac Failure in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Villabona, C | 1 |
| Dabrowska, MD; Krysiak, R; Okopień, B | 1 |
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
| Lee, JD; Shimizu, H; Takeuchi, M; Ueda, T | 1 |
| Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y | 1 |
| Kawano, Y; Matsuoka, H; Nishikimi, T; Saito, Y | 1 |
| Kim, JK; Martin, PY; Meng, X; Morris, K; Ohara, M; Pattison, T; Schrier, RW; St John, J; Xu, DL | 1 |
| Ishikawa, S; Saito, T | 2 |
| Aldred, KL; Burrell, LM; Chan, RK; Johnston, CI; Phillips, PA; Risvanis, J | 1 |
| Burrell, LM; Johnston, CI; Naitoh, M; Phillips, PA; Power, J; Risvanis, J | 1 |
| Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J | 1 |
| Christensen, S; Janjua, NR; Jonassen, TE; Marcussen, N; Nielsen, S; Skøtt, O; Staahltoft, D | 1 |
6 review(s) available for mozavaptan and Cardiac Failure
| Article | Year |
|---|---|
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan | 2012 |
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
[Disorders of body water regulation and the therapy--vasopressin antagonists].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines | 1997 |
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hypertension; Morpholines; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2000 |
8 other study(ies) available for mozavaptan and Cardiac Failure
| Article | Year |
|---|---|
Effects of long-term oral treatment with selective vasopressin V2 receptor antagonist (OPC-31260) on adriamycin-induced heart failure in rats.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Doxorubicin; Heart Failure; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Survival Analysis; Urine; Vasopressins | 2006 |
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium | 1994 |
Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Administration Schedule; Heart Failure; Hemodynamics; Male; Organ Size; Piperidines; Quinolones; Random Allocation; Rats; Rats, Wistar | 1996 |
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.
Topics: Animals; Aquaporin 4; Aquaporins; Benzazepines; Chronic Disease; Gene Expression Regulation; Heart Failure; Immunohistochemistry; Ion Channels; Male; Rats; Rats, Sprague-Dawley; Sodium; Up-Regulation; Water-Electrolyte Balance | 1997 |
Therapeutic efficacy of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuresis; Edema; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Rats | 1998 |
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Female; Heart; Heart Failure; Hemodynamics; Lung; Myocardial Infarction; Organ Size; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Survival Analysis; Systole | 1998 |
Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Heart Failure; Hemodynamics; Ramipril; Sheep; Sodium; Vascular Resistance | 1998 |
Losartan treatment normalizes renal sodium and water handling in rats with mild congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Aquaporin 2; Aquaporin 6; Aquaporins; Benzazepines; Female; Glomerular Filtration Rate; Heart Failure; Kidney Tubules, Collecting; Loop of Henle; Losartan; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Circulation; Sodium; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Vasopressins; Water; Water-Electrolyte Balance | 2002 |